CEO of Tonix Pharmaceuticals Holding Corp (30-Year Financial, Insider Trades) Seth Lederman (insider trades) bought 60,000 shares of TNXP on 08/13/2020 at an average price of $0.91 a share. The total cost of this purchase was $54,600.
Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company dedicated to the development of pharmaceutical products to address public health challenges. Its drug development program is focused on delivering treatment for PTSD. Tonix Pharmaceuticals Holding Corp has a market cap of $139.390 million; its shares were traded at around $1.07 . Tonix Pharmaceuticals Holding Corp had annual average EBITDA growth of 25.10% over the past ten years. GuruFocus has detected 1 severe warning sign with Tonix Pharmaceuticals Holding Corp. .
CEO Recent Trades:
- CEO Seth Lederman bought 60,000 shares of TNXP stock on 08/13/2020 at the average price of $0.91.
Directors and Officers Recent Trades:
- Director James Treco bought 4,500 shares of TNXP stock on 08/14/2020 at the average price of $1.06. The price of the stock has increased by 0.94% since.
- Director Richard H Bagger bought 10,000 shares of TNXP stock on 08/13/2020 at the average price of $0.91.
- Director Adeoye Y Olukotun bought 5,350 shares of TNXP stock on 08/13/2020 at the average price of $0.94.
For the complete insider trading history of TNXP, click here
.
